What's more, the review examined cyclin B, a critical regulator during the G2/M stage of the mobile cycle, which showed a dose-dependent boost in expression in reaction to compound 103f. This final result aligns With all the immediate accumulation of cells within the G2/M phase induced because of the compound. Polysubstance use therapy typically